In Vitro Diagnostics Market Research Reports & Industry Analysis
In Vitro Diagnostics Industry Research & Market Reports
-
Clinical Risk Grouping Solutions
... 2030, growing at a CAGR of 13.8% over the analysis period 2024-2030. Scorecard & Visualization Tools, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$1.1 Billion ... Read More
-
Point of Care (POC) Molecular Diagnostics
... reach US$8.8 Billion by 2030, growing at a CAGR of 12.9% over the analysis period 2024-2030. Infectious Diseases Application, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and ... Read More
-
Automated and Rapid Microbiological Tests
... Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. GC/CRT (Clinical) Application, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$1.3 ... Read More
-
Tissue Diagnostics
... CAGR of 6.6% over the analysis period 2024-2030. Tissue Diagnostics Consumables, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$8.4 Billion by the end of the ... Read More
-
Clinical Chemistry Analyzers
... at a CAGR of 4.9% over the analysis period 2024-2030. Clinical Chemistry Analyzer Reagents, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$12.5 Billion by the ... Read More
-
Automated Blood Tube Labelers and Specimen Transport Boxes
... 2024, is expected to reach US$518.8 Million by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a ... Read More
-
Pathology Instruments
... CAGR of 5.6% over the analysis period 2024-2030. Molecular Diagnostics Technology, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$1.7 Billion by the end of the ... Read More
-
Cancer / Tumor Profiling
... 2030, growing at a CAGR of 9.9% over the analysis period 2024-2030. Immunoassays Technology, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$6.7 Billion by the ... Read More
-
Aptamers
... 15.7% over the analysis period 2024-2030. DNA Aptamers, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$227.5 Million by the end of the analysis period. Growth ... Read More
-
Automated Liquid Handling Systems
... 2030, growing at a CAGR of 10.8% over the analysis period 2024-2030. Automated Liquid Handling Workstations, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$1.6 Billion ... Read More
-
Coagulation Testing
... CAGR of 4.8% over the analysis period 2024-2030. Coagulation Testing Consumables, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.7 Billion by the end of the ... Read More
-
C-Reactive Protein Testing
... at a CAGR of 1.7% over the analysis period 2024-2030. Cardiovascular Diseases, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$1.0 Billion by the end of ... Read More
-
Endocrine Testing
... CAGR of 5.0% over the analysis period 2024-2030. Thyroid Stimulating Hormone (TSH) Testing, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$6.3 Billion by the end ... Read More
-
Fertility Services
... CAGR of 15.0% over the analysis period 2024-2030. Fresh Non-Donor Fertility Services, one of the segments analyzed in the report, is expected to record a 16.1% CAGR and reach US$75.3 Billion by the end of ... Read More
-
Cell Lysis / Cell Fractionation
... Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Cell Lysis / Cell Fractionation Consumables, one of the segments analyzed in the report, is expected to record a 6.7% CAGR ... Read More
-
Cell Signaling
... CAGR of 5.4% over the analysis period 2024-2030. Cell Signaling Consumables, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$4.5 Billion by the end of the ... Read More
-
Cell Proliferation Kits
... at a CAGR of 5.5% over the analysis period 2024-2030. Pharma & Biotech Companies End-Use, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$394.2 Million by ... Read More
-
Influenza Diagnostics
... CAGR of 5.2% over the analysis period 2024-2030. RIDT Test, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$2.0 Billion by the end of the analysis ... Read More
-
Urinalysis
... 5.0% over the analysis period 2024-2030. Urinalysis Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth ... Read More
-
Veterinary Diagnostics
... CAGR of 7.0% over the analysis period 2024-2030. Veterinary Diagnostic Consumables, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$2.6 Billion by the end of the ... Read More
-
Antithrombin
... 5.3% over the analysis period 2024-2030. Therapeutics Application, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$847.5 Million by the end of the analysis period. Growth ... Read More
-
D-dimer Testing
... CAGR of 4.0% over the analysis period 2024-2030. D-dimer Testing Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$1.3 Billion by the end ... Read More
-
Drugs of Abuse Testing
... 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Analyzers, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$2.9 Billion by the end ... Read More
-
Hemostasis Diagnostics
... CAGR of 4.8% over the analysis period 2024-2030. Prothrombin Test Time (PT), one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$1.3 Billion by the end of ... Read More
-
Breath Analyzers
... CAGR of 15.4% over the analysis period 2024-2030. Fuel Cells Technology, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$2.6 Billion by the end of the ... Read More
Research Assistance
